Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.736551
Title: Novel transition metal complexes for use as photosensitizers in photodynamic therapy
Author: McKenzie, Luke Kagiso
ISNI:       0000 0004 6500 4061
Awarding Body: University of Sheffield
Current Institution: University of Sheffield
Date of Award: 2017
Availability of Full Text:
Access from EThOS:
Full text unavailable from EThOS. Thesis embargoed until 15 Feb 2028
Access from Institution:
Abstract:
Herein, the exploration of a range of novel TM complexes for use as PS in the PDT of cancer is reported. Novel small-molecule TM complexes of Pt(II), Os(II) and Ir(III) metal centres were explored. Their photophysical characteristics, such as wavelength of activation and singlet oxygen yields, were assessed for suitability as PS before cellular uptake and toxicity in the dark was determined. Compounds showing favourable cellular uptake and toxicity upon initial screening were explored further. An iridium complex (IrNew) emerged as the most promising PS candidate showing high PS activity and low dark toxicity in a number of cancer cell lines. The mitochondrial localisation and apoptotic mode of cell death of IrNew was determined. With a high photo-toxicity index (up to > 555) at low light doses (3.6 J cm-2) the reported compound is a promising candidate but the need for relatively short wavelength light (405 nm) to activate the compound would severely limit its clinical use. As such alternative modes of activation were explored. An alternative to one-photon activation in PDT is two-photon activation allowing PS activation in the NIR. IrNew, in combination with NIR light (λexc = 760 nm), led photo-induced cell death in cell monolayers (HeLa) clearly demonstrating the potential of IrNew as a two-photon activated PS. The use of 3D oral cancer models as a tool for investigation of tissue effects in PDT were developed for the first time. While two- photon activation offers PS activation in the NIR, the requirement for high power lasers has hindered its clinical application. As an alternative, lanthanide upconverting nanoparticles which can transform two photons of near-infrared (NIR) light into a photon of UV/Vis light to activate the photosensitizer were successfully synthesised. These particles represent potential future treatment modality in the development of continuous wave NIR PDT.
Supervisor: Bryant, Helen ; Weinstein, Julia Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.736551  DOI: Not available
Share: